Demographic, behavioral and clinical characteristics at the start of ART for patients followed at the Evandro Chagas Clinical Research Institute (IPEC) and the Johns Hopkins AIDS Services.

HIV: human immunodeficiency virus, ART: antiretroviral therapy, ADI: AIDS defining illness.aAge at the start of ART.bReported mode of HIV risk exposure was categorized injection drug users (IDU) and not IDUcPre-treatment CD4+ cell count and HIV RNA were defined as the value closest to the date of start of ART up to 6 months prior.dInitial ART regimen was classified as NNRTI-based or PI-based. Integrase inhibitor-based regimens were too few (N = 75) to draw consistent conclusions and were thus excluded.eConcurrent AIDS defining illness (ADI) was defined as the presence of any CDC 1993 condition at six months prior to up to one month after start of ARTfHepatitis B/C co-infection was defined as having chronic infection at the start of ART.